2018 Diagnose Diagnostic Disease 
Imaging Technology
AUGUST 2, 2023
milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman et al.’s
REBEL EM
APRIL 17, 2023
Background: The increased utility and accessibility of point-of-care ultrasound (POCUS) has allowed clinicians the freedom to rethink their diagnostic approach for many common diseases, including peritonsillar abscess (PTA). Clinical evaluation may prove difficult since many PTA and peritonsillar cellulitis symptoms overlap.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
MAY 30, 2023
milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Chief Executive Officer of Blue Earth Diagnostics. Gauden , D.Phil., The adverse reactions reported in ≥0.4%
Imaging Technology
OCTOBER 5, 2023
Specifically, this sub-group examined the performance of flotufolastat F 18 PET in newly diagnosed, high-risk prostate cancer patients who had negative results with conventional imaging. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We Gauden, D.Phil.
AuntMinnie
NOVEMBER 27, 2023
CHICAGO – Black patients receive fewer MRI scans for Alzheimer’s disease diagnosis and undergo imaging at an older age than other racial groups, according to research presented November 27 at RSNA 2023. Additionally, new treatments have recently become available for Alzheimer’s disease that can potentially slow the rate of decline.
Imaging Technology
JULY 28, 2023
POSLUMA is widely available through 36 radiopharmacies in the national network of Blue Earth Diagnostics’ commercial U.S. The addition of POSLUMA to the highly respected NCCN Guidelines is a major milestone for Blue Earth Diagnostics,” said David E. Chief Medical Officer of Blue Earth Diagnostics. Teoh, MBBS, MRCP, FRCR, D.Phil.,
Imaging Technology
JUNE 7, 2023
ClearRead CT with CVI allows radiologists to clearly, confidently, and quickly detect cardiothoracic diseases with Certainty of Search™, and they can then use ClearRead to view additional quantitative information when nodules are detected. “The The Pittsburgh VA Medical Center and H. For more information: [link] Reference: [1] Lo, S.
Expert insights. Personalized for you.
98 
Let's personalize your content